
21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
21.01.2020
3D Genomemedicine Inc is going to operate in USA
Genekam has developed human antibodies (true antibodies, therapeutic antibodies) against H5N1 and now we are working to generate sufficient quantity to conduct other assays!